newsfilter
← Latest News
GlobeNewswire·

INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules

  • INVO Fertility Inc. entered a warrant inducement agreement for the immediate exercise of outstanding December 2025 Warrants.
  • The Investor agreed to exercise 4,733,728 shares at an amended exercise price of $1.59 per share.
  • Gross proceeds from the transaction are expected to be approximately $7.5 million before fees & expenses.
  • Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction.
  • INVO Fertility agreed to issue 9,467,456 unregistered New Warrants with an exercise price of $1.59 per share to the Investor.
  • The New Warrants are subject to shareholder approval & will expire 5.5 years from the approval date.
  • The Company will file an SEC registration statement covering the resale of shares issuable upon exercise of the New Warrants.
  • The transaction closing is expected on or about January 30, 2026, subject to customary conditions.
  • The New Warrants & underlying shares were issued in a private placement exempt from 1933 Act registration requirements.
  • INVO Fertility operates fertility clinics & sells the INVOcell device for intravaginal culture procedures.